Study Significance of Low Plasma Homocysteine or Hypohomocysteinemia and Some Parameter to Syndrome Associated with COVID-19 in Basrah City, Iraq
The increasing interdependence between the countries of the world has led to an increase in the risks faced by societies in general. The COVID-19 pandemic, for example, has transcended national borders, affecting people regardless of nationality, level of education, income or gender. As for its consequences, it has affected the most vulnerable groups. In this study, we have considered the significance of low plasma homocysteine or hypohomocysteinemia and some parameters of the syndrome associated with COVID-19. Just as an increase in the level of homocysteine in plasma has a negative effect on the heart and blood vessels, its decrease may put the health of those who suffer from it at risk. Homocysteine is known to be the natural mediator of the conversion of methionine to cysteine; hence, the danger, as the latter is necessary for the production of glutathione, taurine and sulphate. In this study, homocysteine and some indicators of COVID-19 syndrome were examined using ELISA kit and other methods. The homocysteine level in the serum of people who recovered from COVID-19 was found to be lower than in normal and healthy people. Thus, it indicates that people who have been cured may suffer from hypohomocystinemia. We also study some parameters, such as ALP, GOT, GPT, Glucose level and HDL, cholesterol. The results showed a significant decrease in the level of GOT enzyme and HDL level
Centers for Disease Control and Prevention. Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) Infection, Updated February 12, 2020. https://www.cdc.gov/coronavirus/2019- ncov/hcp/clinical-guidance-managementpatients.html (Accessed on March 26, 2020).
Carroll, M.D., Kit, B.K. and D.A. Lacher (2012). Total and high-density lipoprotein cholesterol in adults, 2009–2010. NCHS data brief no 92. Hyattsville, MD: National Center for Health Statistics; 2012
Fan, Z., Chen, L., Li, J., et al. (2020). Clinical features of COVID-19-related liver damage. Clinical Gastroenterology and Hepatology, 18(7): 1561-1566.
Ganguly, P. and S.F. Alam (2015) Role of homocysteine in the development of cardiovascular disease. USA. Nutrition Journal, 14: 6.
Hui, D.S., Azhar, I.E., Madani, T.A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T.D., Memish, Z.A., Drosten, C., Zumla, A. and E. Petersen (2020). The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis., 91: 264-266. doi:10.1016/j.ijid.2020.01.009. PMID 31953166
Jakubowski, H. (2009). The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J Physiol Pharmacol., 59(Suppl 9): 155-167.
Jin, Y.H., Cai, L., Cheng, Z.S., Cheng, H., Deng, T., Fan, Y.P., et al. (2020). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research, 7(1): 4. doi:10.1186/s40779- 020-0233-6. PMC 7003341. PMID 32029004
Jung, Y.S., Kwak, H.E., Choi, K.H. and Y.C. Kim (2003). Effect of acute ethanol administration on S-amino acid metabolism: Increased utilization of cysteine for synthesis of taurine rather than glutathione. Adv. Exp. Med. Biol., 526: 245-252.
Kalantar-Zadeh, K., Block, G., Humphreys, M.H., McAllister, C.J. and J.D. Kopple (2004). A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol, 15: 442-453
Kalantar-Zadeh, K. (2005). Recent advances in understanding the malnutritioninflammation-cachexia syndrome in chronic kidney disease patients: What is next? Semin. Dial., 18(5): 365-369.
Liu, L. and C.D. Klaassen (1996). Different mechanism of saturation of acetaminophen sulfate conjugation in mice and rats. Toxicol Appl Pharmacol., 139(1): 128-134.
McCully, K.S. (2001). The biomedical significance of homocysteine. J Sci Explor, 15: 5-20.
McCully, K.S. (2007). Homocysteine, vitamins, and vascular disease prevention. Am J Clin Nutr., 86: 1563-1568.
National Institutes of Health (2020). New coronavirus stable for hours on surfaces, Accessed on 17 March 2020. Retrieved 25 March 2020
Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-2019). (February 16-24, 2020). http://www.who.int/docs/default-source/coronaviruse/whochina-jointmission-on-covid-19-final-report.pdf (Accessed on March 25, 2020).
SEOM (Sociedad Española de Oncología Médica) (2020). Las cifras del cáncer en España2020.https://seom.org/seomcms/images/stories/recursos/Cifras_del_cancer_2020
Santoli, J.M., Lindley, M.C., DeSilva, M.B., Kharbanda, E.O., Daley, M.F., Galloway, L., Julianne, G., et al. (2020). Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration — the United States, 2020. MMWR. Morbidity and Mortality Weekly Report, 69(19): 591593. https://doi.org/10.15585/ mmwr.mm6919e2
Satyanarayana U. and U. Chakrapani (2006). In: Biochemistry. 3rd ed. Kolkata (India): Books and Allied (P) Ltd. p. 360- 361.
Vitvitsky, V., Mosharov, E., Tritt, M., Ataullakhanov, F. and R. Banerjee (2003). Redox regulation of homocysteinedependent glutathione synthesis. Redox Rep., 8(1): 57-63.
Worldometer (2020). COVID-19 Coronavirus Pandemic, 2020 Available at: https://www.worldometers.info/ coronavirus/ Accessed on: 2020 March 29
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., Tai, Y., Bai, C., Gao, T., Song, J., Xia, P., Dong, J., Zhao, J. and F.S. Wang (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med., 8: 420-422.
Zhang, C., Shi, L. and F.S. Wang (2020). Liver injury in COVID-19: Management and challenges. The Lancet Gastroenterology & Hepatology, 5(5): 428-430